Chemotherapy and endocrine therapy in metastatic disease.
Pritchard
K I
KI
Toronto-Bayview Regional Cancer Center, Ontario, Canada.
D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000188:drug therapy*; D004965:Estrogen Antagonists / Q000627:therapeutic use; D005260:Female; D007987:Gonadotropin-Releasing Hormone / Q000031:analogs & derivatives; D006728:Hormones / Q000627:therapeutic use*; D006801:Humans; D009362:Neoplasm Metastasis; D011372:Progestins / Q000037:antagonists & inhibitors
D000970:Antineoplastic Agents; D004965:Estrogen Antagonists; D006728:Hormones; D011372:Progestins; D007987:Gonadotropin-Releasing Hormone